117 related articles for article (PubMed ID: 36867057)
1. Long-term milrinone therapy in children with dilated cardiomyopathy.
Brown S; Nolan O; Poole E; Kidd J; Cassidy J; Botha P; Chaudhari M
Acta Paediatr; 2023 Jun; 112(6):1298-1303. PubMed ID: 36867057
[TBL] [Abstract][Full Text] [Related]
2. Single-centred experience with levosimendan in paediatric decompensated dilated cardiomyopathy.
Séguéla PE; Mauriat P; Mouton JB; Tafer N; Assy J; Poncelet G; Nubret K; Iriart X; Thambo JB
Arch Cardiovasc Dis; 2015; 108(6-7):347-55. PubMed ID: 25863426
[TBL] [Abstract][Full Text] [Related]
3. Continuous Intravenous Milrinone Therapy in Pediatric Outpatients.
Curley M; Liebers J; Maynard R
J Infus Nurs; 2017; 40(2):92-96. PubMed ID: 28248808
[TBL] [Abstract][Full Text] [Related]
4. Long-term support with milrinone prior to cardiac transplantation in a neonate with left ventricular noncompaction cardiomyopathy.
McMahon CJ; Murchan H; Prendiville T; Burch M
Pediatr Cardiol; 2007; 28(4):317-8. PubMed ID: 17551772
[TBL] [Abstract][Full Text] [Related]
5. Assessment of inotropic and vasodilating effects of milrinone lactate in patients with dilated cardiomyopathy and severe heart failure.
Bregagnollo EA; Fortes AH; Cicogna AC
Arq Bras Cardiol; 1999 Feb; 72(2):149-60. PubMed ID: 10488574
[TBL] [Abstract][Full Text] [Related]
6. Ambulatory Intravenous Inotropic Support and or Levosimendan in Pediatric and Congenital Heart Failure: Safety, Survival, Improvement, or Transplantation.
Apostolopoulou SC; Vagenakis GA; Tsoutsinos A; Kakava F; Rammos S
Pediatr Cardiol; 2018 Oct; 39(7):1315-1322. PubMed ID: 29777282
[TBL] [Abstract][Full Text] [Related]
7. NT-proBNP as a marker for persistent cardiac disease in children with history of dilated cardiomyopathy and myocarditis.
Nasser N; Perles Z; Rein AJJT; Nir A
Pediatr Cardiol; 2006; 27(1):87-90. PubMed ID: 16132296
[TBL] [Abstract][Full Text] [Related]
8. How mechanical circulatory support helps not to need it--new strategies in pediatric heart failure.
Schweigmann U; Velik-Salchner C; Kilo J; Schermer E
Artif Organs; 2011 Nov; 35(11):1105-9. PubMed ID: 21954874
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience of milrinone as a pharmacological bridge to heart transplantation.
Koyanagi T; Kyo S; Ouchi H; Asano H; Yokote Y; Omoto R
Jpn J Thorac Cardiovasc Surg; 2000 Jul; 48(7):460-3. PubMed ID: 10965621
[TBL] [Abstract][Full Text] [Related]
10. Comparison of intravenous milrinone and dobutamine for congestive heart failure secondary to either ischemic or dilated cardiomyopathy.
Biddle TL; Benotti JR; Creager MA; Faxon DP; Firth BG; Fitzpatrick PG; Konstam MA; Krebs C; Walton L; Kershner RP
Am J Cardiol; 1987 Jun; 59(15):1345-50. PubMed ID: 3591689
[TBL] [Abstract][Full Text] [Related]
11. Home Milrinone in Pediatric Hospice Care of Children with Heart Failure.
Hollander SA; Wujcik K; Schmidt J; Liu E; Lin A; Dykes J; Good J; Brown M; Rosenthal D
J Pain Symptom Manage; 2023 Mar; 65(3):216-221. PubMed ID: 36417945
[TBL] [Abstract][Full Text] [Related]
12. Improvement of postreceptor events by metoprolol treatment in patients with chronic heart failure.
Böhm M; Deutsch HJ; Hartmann D; Rosée KL; Stäblein A
J Am Coll Cardiol; 1997 Oct; 30(4):992-6. PubMed ID: 9316529
[TBL] [Abstract][Full Text] [Related]
13. Upgraded heart failure therapy leads to an improved outcome of dilated cardiomyopathy in infants and toddlers.
Rupp S; Apitz C; Tholen L; Latus H; Ostermayer SH; Schmidt D; Bauer J; Schranz D
Cardiol Young; 2015 Oct; 25(7):1300-5. PubMed ID: 25498517
[TBL] [Abstract][Full Text] [Related]
14. Left ventricular reverse remodeling with infantile dilated cardiomyopathy and pitfalls of carvedilol therapy.
Tsuda E; Negishi J; Noritake K; Iwasa T; Abe T
J Cardiol; 2016 Feb; 67(2):147-52. PubMed ID: 26572957
[TBL] [Abstract][Full Text] [Related]
15. Long-term milrinone therapy as a bridge to heart transplantation: Safety, efficacy, and predictors of failure.
Lee EC; McNitt S; Martens J; Bruckel JT; Chen L; Alexis JD; Storozynsky E; Thomas S; Gosev I; Barrus B; Goldenberg I; Vidula H
Int J Cardiol; 2020 Aug; 313():83-88. PubMed ID: 32320777
[TBL] [Abstract][Full Text] [Related]
16. Competing risks for death and cardiac transplantation in children with dilated cardiomyopathy: results from the pediatric cardiomyopathy registry.
Alvarez JA; Orav EJ; Wilkinson JD; Fleming LE; Lee DJ; Sleeper LA; Rusconi PG; Colan SD; Hsu DT; Canter CE; Webber SA; Cox GF; Jefferies JL; Towbin JA; Lipshultz SE;
Circulation; 2011 Aug; 124(7):814-23. PubMed ID: 21788591
[TBL] [Abstract][Full Text] [Related]
17. The Hemodynamic Effects and Safety of Repetitive Levosimendan Infusions on Children With Dilated Cardiomyopathy.
Suominen P; Mattila N; Nyblom O; Rautiainen P; Turanlahti M; Rahkonen O
World J Pediatr Congenit Heart Surg; 2017 Jan; 8(1):25-31. PubMed ID: 28033083
[TBL] [Abstract][Full Text] [Related]
18. Is Myocarditis an Independent Risk Factor for Post-Transplant Mortality in Pediatric Heart Transplant Recipients?
Garbern JC; Gauvreau K; Blume ED; Singh TP
Circ Heart Fail; 2016 Jan; 9(1):e002328. PubMed ID: 26699389
[TBL] [Abstract][Full Text] [Related]
19. The use of continuous milrinone therapy as bridge to transplant is safe in patients with short waiting times.
Assad-Kottner C; Chen D; Jahanyar J; Cordova F; Summers N; Loebe M; Merla R; Youker K; Torre-Amione G
J Card Fail; 2008 Dec; 14(10):839-43. PubMed ID: 19041047
[TBL] [Abstract][Full Text] [Related]
20. Home inotropic therapy in children.
Berg AM; Snell L; Mahle WT
J Heart Lung Transplant; 2007 May; 26(5):453-7. PubMed ID: 17449413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
